ecrin-mdr-crcClinical2004Colorectal CancerColorectal NeoplasmsColorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2020223Japan1IrinotecanIrinotecan, S-1, Phase II, colorectal cancer,ECRIN MDRNot providedfalsePhase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal CancerTo assess the usefulness of irinotecan plus S-1 therapy based on the antitumor effect and survival period. by performing a phase II study of this combination in patients with inoperable or with postoperative colorectal cancer.2004-01-152020223NCT00209651